349 related articles for article (PubMed ID: 33596993)
1. Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial.
Deehan EC; Colin-Ramirez E; Triador L; Madsen KL; Prado CM; Field CJ; Ball GDC; Tan Q; Orsso C; Dinu I; Pakseresht M; Rubin D; Sharma AM; Tun H; Walter J; Newgard CB; Freemark M; Wine E; Haqq AM
Trials; 2021 Feb; 22(1):148. PubMed ID: 33596993
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
[TBL] [Abstract][Full Text] [Related]
3. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
4. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial.
Feig DS; Murphy K; Asztalos E; Tomlinson G; Sanchez J; Zinman B; Ohlsson A; Ryan EA; Fantus IG; Armson AB; Lipscombe LL; Barrett JF;
BMC Pregnancy Childbirth; 2016 Jul; 16(1):173. PubMed ID: 27435163
[TBL] [Abstract][Full Text] [Related]
5. METFORMIN: an efficacy, safety and pharmacokinetic study on the short-term and long-term use in obese children and adolescents - study protocol of a randomized controlled study.
van der Aa MP; Elst MA; van Mil EG; Knibbe CA; van der Vorst MM
Trials; 2014 Jun; 15():207. PubMed ID: 24899137
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the role of the gut microbiota in the physiological effects of dietary fiber.
Deehan EC; Zhang Z; Riva A; Armet AM; Perez-Muñoz ME; Nguyen NK; Krysa JA; Seethaler B; Zhao YY; Cole J; Li F; Hausmann B; Spittler A; Nazare JA; Delzenne NM; Curtis JM; Wismer WV; Proctor SD; Bakal JA; Bischoff SC; Knights D; Field CJ; Berry D; Prado CM; Walter J
Microbiome; 2022 May; 10(1):77. PubMed ID: 35562794
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.
Stagi S; Ricci F; Bianconi M; Sammarco MA; Municchi G; Toni S; Lenzi L; Verrotti A; de Martino M
Nutrients; 2017 May; 9(5):. PubMed ID: 28531113
[No Abstract] [Full Text] [Related]
10. Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial.
Pastor-Villaescusa B; Caballero-Villarraso J; Cañete MD; Hoyos R; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
Trials; 2016 Jul; 17(1):323. PubMed ID: 27432166
[TBL] [Abstract][Full Text] [Related]
11. Metformin, testosterone, or both in men with obesity and low testosterone: A double-blind, parallel-group, randomized controlled trial.
Fernández-García JC; Barrios-Rodríguez R; Asenjo-Plaza M; Ramos-Molina B; Molina-Vega M; Guzmán-Guzmán A; Moreno-León L; Yubero-Serrano EM; Rius-Díaz F; Valdés S; Martínez-González MÁ; Jiménez-Moleón JJ; Tinahones FJ
Metabolism; 2022 Nov; 136():155290. PubMed ID: 35985506
[TBL] [Abstract][Full Text] [Related]
12. Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study.
Nadeau KJ; Chow K; Alam S; Lindquist K; Campbell S; McFann K; Klingensmith G; Walravens P
Pediatr Diabetes; 2015 May; 16(3):196-203. PubMed ID: 24698216
[TBL] [Abstract][Full Text] [Related]
13. Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial.
Agarwal SM; Panda R; Costa-Dookhan KA; MacKenzie NE; Treen QC; Caravaggio F; Hashim E; Leung G; Kirpalani A; Matheson K; Chintoh AF; Kramer CK; Voineskos AN; Graff-Guerrero A; Remington GJ; Hahn MK
Transl Psychiatry; 2021 Apr; 11(1):219. PubMed ID: 33854039
[TBL] [Abstract][Full Text] [Related]
14. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: The Gut Bugs Randomized Controlled Trial.
Leong KSW; Jayasinghe TN; Wilson BC; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
JAMA Netw Open; 2020 Dec; 3(12):e2030415. PubMed ID: 33346848
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.
Mocanu V; Zhang Z; Deehan EC; Kao DH; Hotte N; Karmali S; Birch DW; Samarasinghe KK; Walter J; Madsen KL
Nat Med; 2021 Jul; 27(7):1272-1279. PubMed ID: 34226737
[TBL] [Abstract][Full Text] [Related]
17. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
18. Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.
Cree-Green M; Bergman BC; Cengiz E; Fox LA; Hannon TS; Miller K; Nathan B; Pyle L; Kahn D; Tansey M; Tichy E; Tsalikian E; Libman I; Nadeau KJ
J Clin Endocrinol Metab; 2019 Aug; 104(8):3265-3278. PubMed ID: 30938764
[TBL] [Abstract][Full Text] [Related]
19. Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial.
Lee SE; Choi Y; Jun JE; Lee YB; Jin SM; Hur KY; Ko GP; Lee MK
Diabetes Metab J; 2019 Aug; 43(4):422-431. PubMed ID: 31237126
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.
Perez A; Zhao Z; Jacks R; Spanheimer R
Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
